T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients.
Biomedicines
; 10(10)2022 Sep 27.
Article
in En
| MEDLINE
| ID: mdl-36289679
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Biomedicines
Year:
2022
Type:
Article
Affiliation country:
France